Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25891173

Pembrolizumab versus Ipilimumab in Advanced Melanoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2015 Jun 25
First author
Robert C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2015 Jul;12(7):371. doi: 10.1038/nrclinonc.2015.85.
    note
    Source null
    related pmid
    25963092
    relationship
    Comment in

Authors and identifiers

  1. name
    Robert C
    type
    Author
  2. name
    Schachter J
    type
    Author
  3. name
    Long GV
    type
    Author
  4. name
    Arance A
    type
    Author
  5. name
    Grob JJ
    type
    Author
  6. name
    Mortier L
    type
    Author
  7. name
    Daud A
    type
    Author
  8. name
    Carlino MS
    type
    Author
  9. name
    McNeil C
    type
    Author
  10. name
    Lotem M
    type
    Author
  11. name
    Larkin J
    type
    Author
  12. name
    Lorigan P
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Robert C
    type
    Author
  2. name
    Schachter J
    type
    Author
  3. name
    Long GV
    type
    Author
  4. name
    Arance A
    type
    Author
  5. name
    Grob JJ
    type
    Author
  6. name
    Mortier L
    type
    Author
  7. name
    Daud A
    type
    Author
  8. name
    Carlino MS
    type
    Author
  9. name
    McNeil C
    type
    Author
  10. name
    Lotem M
    type
    Author
  11. name
    Larkin J
    type
    Author
  12. name
    Lorigan P
    type
    Author
bibliography ids
  1. nci-bib-f9c651887ecd26fbe9b87a70
book metadata
content sha256
e1436a9871b2fad58046e92a12866d0c398dcdb4c11f2c45d23074f66508aeda
document type
citation
dois
  1. 10.1056/NEJMoa1503093
electronic publication date
display
2015 Apr 19
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:25891173
immutable id
pubmed:25891173@e1436a9871b2fad58046e92a12866d0c398dcdb4c11f2c45d23074f66508aeda
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
26
name
The New England journal of medicine
nlm unique id
0255562
pages
2521-32
volume
372
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2015 Jul;12(7):371. doi: 10.1038/nrclinonc.2015.85.
    note
    Source null
    related pmid
    25963092
    relationship
    Comment in
outcomes validated
false
pmid
25891173
provenance
batch id
74265f1b641f04cf2d05
provider
NCBI PubMed ESummary
record sha256
7d4a3f05ad266eff7fd7f437902947308c8961cc14c5d8ff8594111815fca5c2
response sha256
193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
retrieved at
2026-09-09T23:47:10.134322+00:00
publication date
display
2015 Jun 25
precision
day
year
2015
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25891173/
title
Pembrolizumab versus Ipilimumab in Advanced Melanoma.

Preserved source evidence · Not medical advice